adtralza
leo pharma a/s - tralokinumab - dermatitis, atópísk - aðrar húðsjúkdómar - adtralza is indicated for the treatment of moderate to severe atopic dermatitis in adult and adolescent patients 12 years and older who are candidates for systemic therapy.
aprepitant stada hart hylki 125 mg/80 mg
stada arzneimittel ag - aprepitantum inn - hart hylki - 125 mg/80 mg
fluconazol krka hart hylki 150 mg
krka sverige ab - fluconazolum inn - hart hylki - 150 mg
clarithromycin krka filmuhúðuð tafla 250 mg
krka, d.d., novo mesto - clarithromycinum inn - filmuhúðuð tafla - 250 mg
bisoprolol medical valley filmuhúðuð tafla 5 mg
medical valley invest ab - bisoprololum fúmarat - filmuhúðuð tafla - 5 mg
clarithromycin krka filmuhúðuð tafla 500 mg
krka, d.d., novo mesto - clarithromycinum inn - filmuhúðuð tafla - 500 mg
posaconazole stada magasýruþolin tafla 100 mg
stada arzneimittel ag - posaconazolum inn - magasýruþolin tafla - 100 mg
bicalutamid medical (bicalutamide synthon) filmuhúðuð tafla 50 mg
medical ehf. - bicalutamidum inn - filmuhúðuð tafla - 50 mg
bicalutamide alvogen (bicalutamide portfarma) filmuhúðuð tafla 150 mg
alvogen ehf. - bicalutamidum inn - filmuhúðuð tafla - 150 mg
bicalutamide alvogen (bicalutamide portfarma) filmuhúðuð tafla 50 mg
alvogen ehf. - bicalutamidum inn - filmuhúðuð tafla - 50 mg